Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 1129

1.

Risk for unemployment at 10 years following cancer diagnosis among very long-term survivors: a population based study.

Rottenberg Y, de Boer AGEM.

J Cancer Surviv. 2020 Feb 14. doi: 10.1007/s11764-020-00858-y. [Epub ahead of print]

PMID:
32060878
2.

Risk of major bleeding among users of direct oral anticoagulants combined with interacting drugs: a population-based nested case-control study.

Zhang Y, Souverein PC, Gardarsdottir H, van den Ham HA, Maitland-van der Zee AH, de Boer A.

Br J Clin Pharmacol. 2020 Feb 5. doi: 10.1111/bcp.14227. [Epub ahead of print]

PMID:
32022295
3.

Supporting employers to enhance the return to work of cancer survivors: development of a web-based intervention (MiLES intervention).

Greidanus MA, de Boer AGEM, Tiedtke CM, Frings-Dresen MHW, de Rijk AE, Tamminga SJ.

J Cancer Surviv. 2020 Jan 14. doi: 10.1007/s11764-019-00844-z. [Epub ahead of print]

PMID:
31938966
4.

The Influence of Radiograph Obliquity on Böhler's and Gissane's Angles in Calcanei.

De Boer AS, Van Lieshout EMM, Vellekoop L, Den Hartog D, Kleinrensink GJ, Verhofstad MHJ.

J Foot Ankle Surg. 2020 Jan - Feb;59(1):44-47. doi: 10.1053/j.jfas.2019.02.004.

PMID:
31882146
5.

The development of a test battery to assess the hand-eye functions relevant in predicting easy and accurate tablet subdivision in older people: A pilot study.

van Riet-Nales D, Donkerbroek L, Nicia A, Oussoren C, de Boer A, van den Bemt B.

Br J Clin Pharmacol. 2019 Dec 25. doi: 10.1111/bcp.14201. [Epub ahead of print]

PMID:
31875976
6.

Pulmonary immunization: deposition site is of minor relevance for influenza vaccination but deep lung deposition is crucial for hepatitis B vaccination.

Tomar J, Tonnis WF, Patil HP, de Boer AH, Hagedoorn P, Vanbever R, Frijlink HW, Hinrichs WLJ.

Acta Pharm Sin B. 2019 Nov;9(6):1231-1240. doi: 10.1016/j.apsb.2019.05.003. Epub 2019 May 28.

7.

EphA4 loss improves social memory performance and alters dendritic spine morphology without changes in amyloid pathology in a mouse model of Alzheimer's disease.

Poppe L, Rué L, Timmers M, Lenaerts A, Storm A, Callaerts-Vegh Z, Courtand G, de Boer A, Smolders S, Van Damme P, Van Den Bosch L, D'Hooge R, De Strooper B, Robberecht W, Lemmens R.

Alzheimers Res Ther. 2019 Dec 12;11(1):102. doi: 10.1186/s13195-019-0554-4.

8.

Environmental enrichment during the chronic phase after experimental stroke promotes functional recovery without synergistic effects of EphA4 targeted therapy.

de Boer A, Storm A, Soler MG, Smolders S, Rué L, Poppe L, Pasquale E, Robberecht W, Lemmens R.

Hum Mol Genet. 2019 Dec 9. pii: ddz288. doi: 10.1093/hmg/ddz288. [Epub ahead of print]

PMID:
31814004
9.

Comparison of multi-delay FAIR and pCASL labeling approaches for renal perfusion quantification at 3T MRI.

Harteveld AA, de Boer A, Franklin SL, Leiner T, van Stralen M, Bos C.

MAGMA. 2020 Feb;33(1):81-94. doi: 10.1007/s10334-019-00806-7. Epub 2019 Dec 6.

PMID:
31811490
10.

Lowering EphA4 Does Not Ameliorate Disease in a Mouse Model for Severe Spinal Muscular Atrophy.

Poppe L, Smolders S, Rué L, Timmers M, Lenaerts A, Storm A, Schoonaert L, de Boer A, Van Damme P, Van Den Bosch L, Robberecht W, Lemmens R.

Front Neurosci. 2019 Nov 19;13:1233. doi: 10.3389/fnins.2019.01233. eCollection 2019.

11.

Decreased native renal T1 up to one week after gadobutrol administration in healthy volunteers.

de Boer A, Harteveld AA, Pieters TT, Blankestijn PJ, Bos C, Froeling M, Joles JA, Verhaar MC, Leiner T, Hoogduin H.

J Magn Reson Imaging. 2019 Dec 4. doi: 10.1002/jmri.27014. [Epub ahead of print]

PMID:
31799793
12.

C-reactive protein as a biomarker of response to inhaled corticosteroids among patients with COPD.

Oshagbemi OA, Franssen FME, Wouters EFM, Maitland-van der Zee AH, Driessen JHM, de Boer A, de Vries F.

Pulm Pharmacol Ther. 2020 Feb;60:101870. doi: 10.1016/j.pupt.2019.101870. Epub 2019 Nov 27.

13.

Melancholia as Predictor of Electroconvulsive Therapy Outcome in Later Life.

Veltman EM, de Boer A, Dols A, van Exel E, Stek ML, Sienaert P, Bouckaert F, van der Mast R, Rhebergen D.

J ECT. 2019 Dec;35(4):231-237. doi: 10.1097/YCT.0000000000000579.

PMID:
31764445
14.

The challenge of return to work in workers with cancer: employer priorities despite variation in social policies related to work and health.

de Rijk A, Amir Z, Cohen M, Furlan T, Godderis L, Knezevic B, Miglioretti M, Munir F, Popa AE, Sedlakova M, Torp S, Yagil D, Tamminga S, de Boer A.

J Cancer Surviv. 2019 Nov 22. doi: 10.1007/s11764-019-00829-y. [Epub ahead of print]

PMID:
31758518
15.

Consensus-based technical recommendations for clinical translation of renal T1 and T2 mapping MRI.

Dekkers IA, de Boer A, Sharma K, Cox EF, Lamb HJ, Buckley DL, Bane O, Morris DM, Prasad PV, Semple SIK, Gillis KA, Hockings P, Buchanan C, Wolf M, Laustsen C, Leiner T, Haddock B, Hoogduin JM, Pullens P, Sourbron S, Francis S.

MAGMA. 2020 Feb;33(1):163-176. doi: 10.1007/s10334-019-00797-5. Epub 2019 Nov 22. Review.

PMID:
31758418
16.

Medication safety in patients with hepatic impairment: A survey of community pharmacists' knowledge level and their practice in caring for these patients.

Weersink RA, Abadier M, de Boer A, Taxis K, Borgsteede SD.

Br J Clin Pharmacol. 2019 Nov 22. doi: 10.1111/bcp.14177. [Epub ahead of print]

PMID:
31756269
17.

Home care for terminally ill patients: the experiences of family caregivers with and without paid work.

Bijnsdorp FM, van der Beek AJ, Pasman HRW, Boot CRL, de Boer AH, Plaisier I, Onwuteaka-Philipsen BD.

BMJ Support Palliat Care. 2019 Nov 20. pii: bmjspcare-2019-001949. doi: 10.1136/bmjspcare-2019-001949. [Epub ahead of print]

PMID:
31748201
18.

Process evaluation of a tailored work-related support intervention for patients diagnosed with gastrointestinal cancer.

Zaman AGNM, Tytgat KMAJ, Klinkenbijl JHG, de Boer AGEM, Frings-Dresen MHW.

J Cancer Surviv. 2020 Feb;14(1):59-71. doi: 10.1007/s11764-019-00797-3. Epub 2019 Nov 19.

PMID:
31745819
19.

Statins After Myocardial Infarction in the Oldest: A Cohort Study in the Clinical Practice Research Datalink Database.

Lefeber GJ, Koek HL, Souverein PC, Bouvy ML, de Boer A, Knol W.

J Am Geriatr Soc. 2020 Feb;68(2):329-336. doi: 10.1111/jgs.16227. Epub 2019 Oct 24.

PMID:
31647578
20.

Technical recommendations for clinical translation of renal MRI: a consensus project of the Cooperation in Science and Technology Action PARENCHIMA.

Mendichovszky I, Pullens P, Dekkers I, Nery F, Bane O, Pohlmann A, de Boer A, Ljimani A, Odudu A, Buchanan C, Sharma K, Laustsen C, Harteveld A, Golay X, Pedrosa I, Alsop D, Fain S, Caroli A, Prasad P, Francis S, Sigmund E, Fernández-Seara M, Sourbron S.

MAGMA. 2020 Feb;33(1):131-140. doi: 10.1007/s10334-019-00784-w. Epub 2019 Oct 18.

21.

The Implementation of Workers' Health Surveillance by Occupational Physicians: A Survey Study.

Los FS, de Boer AGEM, van der Molen HF, Hulshof CTJ.

J Occup Environ Med. 2019 Dec;61(12):e497-e502. doi: 10.1097/JOM.0000000000001740.

PMID:
31626069
22.

Mortality risk in atrial fibrillation: the role of aspirin, vitamin K and non-vitamin K antagonists.

Gieling E, de Vries F, Williams R, van Onzenoort HAW, de Boer A, Ten Cate V, Kramers C, Burden A.

Int J Clin Pharm. 2019 Dec;41(6):1536-1544. doi: 10.1007/s11096-019-00916-1. Epub 2019 Oct 8.

PMID:
31595448
23.

Reducing EphA4 before disease onset does not affect survival in a mouse model of Amyotrophic Lateral Sclerosis.

Rué L, Timmers M, Lenaerts A, Smolders S, Poppe L, de Boer A, Van Den Bosch L, Van Damme P, Robberecht W, Lemmens R.

Sci Rep. 2019 Oct 1;9(1):14112. doi: 10.1038/s41598-019-50615-0.

24.

Impact of Older Age and Comorbidity on Locoregional and Distant Breast Cancer Recurrence: A Large Population-Based Study.

de Boer AZ, van der Hulst HC, de Glas NA, Marang-van de Mheen PJ, Siesling S, de Munck L, de Ligt KM, Portielje JEA, Bastiaannet E, Liefers GJ.

Oncologist. 2020 Jan;25(1):e24-e30. doi: 10.1634/theoncologist.2019-0412. Epub 2019 Sep 12.

25.

Differential effects on out-of-hospital cardiac arrest of dihydropyridines: real-world data from population-based cohorts across two European countries.

Eroglu TE, Mohr GH, Blom MT, Verkerk AO, Souverein PC, Torp-Pedersen C, Folke F, Wissenberg M, van den Brink L, Davis RP, de Boer A, Gislason GH, Tan HL.

Eur Heart J Cardiovasc Pharmacother. 2019 Aug 10. pii: pvz038. doi: 10.1093/ehjcvp/pvz038. [Epub ahead of print]

PMID:
31504369
26.

A Genotype-Guided Strategy for Oral P2Y12 Inhibitors in Primary PCI.

Claassens DMF, Vos GJA, Bergmeijer TO, Hermanides RS, van 't Hof AWJ, van der Harst P, Barbato E, Morisco C, Tjon Joe Gin RM, Asselbergs FW, Mosterd A, Herrman JR, Dewilde WJM, Janssen PWA, Kelder JC, Postma MJ, de Boer A, Boersma C, Deneer VHM, Ten Berg JM.

N Engl J Med. 2019 Oct 24;381(17):1621-1631. doi: 10.1056/NEJMoa1907096. Epub 2019 Sep 3.

PMID:
31479209
27.

Renal sinus fat and renal hemodynamics: a cross-sectional analysis.

Spit KA, Muskiet MHA, Tonneijck L, Smits MM, Kramer MHH, Joles JA, de Boer A, van Raalte DH.

MAGMA. 2020 Feb;33(1):73-80. doi: 10.1007/s10334-019-00773-z. Epub 2019 Aug 31.

PMID:
31471702
28.

Effectiveness of radiotherapy after breast-conserving surgery in older patients with T1-2N0 breast cancer.

de Boer AZ, Bastiaannet E, de Glas NA, Marang-van de Mheen PJ, Dekkers OM, Siesling S, de Munck L, de Ligt KM, Portielje JEA, Liefers GJ.

Breast Cancer Res Treat. 2019 Dec;178(3):637-645. doi: 10.1007/s10549-019-05412-8. Epub 2019 Aug 26.

29.

Arctic closure as a trigger for Atlantic overturning at the Eocene-Oligocene Transition.

Hutchinson DK, Coxall HK, OʹRegan M, Nilsson J, Caballero R, de Boer AM.

Nat Commun. 2019 Aug 22;10(1):3797. doi: 10.1038/s41467-019-11828-z.

30.

Risk of Nephrotic Syndrome for Non-Steroidal Anti-Inflammatory Drug Users.

Bakhriansyah M, Souverein PC, van den Hoogen MWF, de Boer A, Klungel OH.

Clin J Am Soc Nephrol. 2019 Sep 6;14(9):1355-1362. doi: 10.2215/CJN.14331218. Epub 2019 Aug 15.

PMID:
31416888
31.

Scientific assessments in European food law: Making it future-proof.

de Boer A.

Regul Toxicol Pharmacol. 2019 Nov;108:104437. doi: 10.1016/j.yrtph.2019.104437. Epub 2019 Aug 3. Review.

32.

Amiodarone use and the risk of acute pancreatitis: Influence of different exposure definitions.

Hempenius M, Groenwold RHH, de Boer A, Klungel OH, Gardarsdottir H.

Pharmacoepidemiol Drug Saf. 2019 Dec;28(12):1563-1571. doi: 10.1002/pds.4851. Epub 2019 Aug 2.

33.

Measuring the impact of pharmacovigilance activities, challenging but important.

van Hunsel F, Gardarsdottir H, de Boer A, Kant A.

Br J Clin Pharmacol. 2019 Oct;85(10):2235-2237. doi: 10.1111/bcp.14042. Epub 2019 Jul 31. No abstract available.

PMID:
31368147
34.

Improved survival of older patients with advanced breast cancer due to an increase in systemic treatments: a population-based study.

de Glas N, Bastiaannet E, de Boer A, Siesling S, Liefers GJ, Portielje J.

Breast Cancer Res Treat. 2019 Nov;178(1):141-149. doi: 10.1007/s10549-019-05356-z. Epub 2019 Jul 19.

35.

Reduction of ephrin-A5 aggravates disease progression in amyotrophic lateral sclerosis.

Rué L, Oeckl P, Timmers M, Lenaerts A, van der Vos J, Smolders S, Poppe L, de Boer A, Van Den Bosch L, Van Damme P, Weishaupt JH, Ludolph AC, Otto M, Robberecht W, Lemmens R.

Acta Neuropathol Commun. 2019 Jul 12;7(1):114. doi: 10.1186/s40478-019-0759-6.

36.

Pharmacokinetics and tolerability of inhaled levodopa from a new dry-powder inhaler in patients with Parkinson's disease.

Luinstra M, Rutgers W, van Laar T, Grasmeijer F, Begeman A, Isufi V, Steenhuis L, Hagedoorn P, de Boer A, Frijlink HW.

Ther Adv Chronic Dis. 2019 Jun 21;10:2040622319857617. doi: 10.1177/2040622319857617. eCollection 2019.

37.

A limited number of medicines pragmatic trials had potential for waived informed consent following the 2016 CIOMS ethical guidelines.

Dal-Ré R, Avendaño-Solà C, de Boer A, James SK, Rosendaal FR, Stephens R, Ioannidis JPA.

J Clin Epidemiol. 2019 Oct;114:60-71. doi: 10.1016/j.jclinepi.2019.06.007. Epub 2019 Jun 15.

PMID:
31212001
38.

Obtaining person-related information from employees with chronic health problems: a focus group study.

de Wit M, Wind H, Hulshof CTJ, de Boer AGEM.

Int Arch Occup Environ Health. 2019 Oct;92(7):1003-1012. doi: 10.1007/s00420-019-01440-5. Epub 2019 May 18.

39.

Informal caregivers' judgements on sharing care with home care professionals from an intersectional perspective: the influence of personal and situational characteristics.

Wittenberg Y, de Boer A, Plaisier I, Verhoeff A, Kwekkeboom R.

Scand J Caring Sci. 2019 Dec;33(4):1006-1016. doi: 10.1111/scs.12699. Epub 2019 Apr 29. Review.

40.

In-Flight Observation of Positron Annihilation by ILDAS.

Kochkin P, Sarria D, Skeie C, van Deursen APJ, de Boer AI, Bardet M, Allasia C, Flourens F, Østgaard N.

J Geophys Res Atmos. 2018 Aug 16;123(15):8074-8090. doi: 10.1029/2018JD028337. Epub 2018 Aug 3.

41.

A qualitative study investigating the meaning of participation to improve the measurement of this construct.

de Wind A, van der Beek AJ, Boezeman EJ, Swenneker R, Anema JR, de Boer AGEM, Beckerman H, Hoving JL, Nieuwenhuijsen K, Scharn M, Stam M, Terwee CB, Frings-Dresen MHW, Tamminga SJ.

Qual Life Res. 2019 Aug;28(8):2233-2246. doi: 10.1007/s11136-019-02179-9. Epub 2019 Apr 16.

42.

How Is End-of-Life Care With and Without Dementia Associated With Informal Caregivers' Outcomes?

Boogaard JA, van der Steen JT, de Boer AH, van Groenou MIB.

Am J Hosp Palliat Care. 2019 Nov;36(11):1008-1015. doi: 10.1177/1049909119836932. Epub 2019 Apr 14.

43.

Analysis of Arabidopsis thaliana HKT1 and Eutrema salsugineum/botschantzevii HKT1;2 Promoters in Response to Salt Stress in Athkt1:1 Mutant.

Nawaz I, Iqbal M, Hakvoort HWJ, de Boer AH, Schat H.

Mol Biotechnol. 2019 Jun;61(6):442-450. doi: 10.1007/s12033-019-00175-5.

PMID:
30980224
44.

Conditional Financing of Drugs in the Netherlands: Past, Present, and Future-Results From Stakeholder Interviews.

Makady A, van Acker S, Nijmeijer H, de Boer A, Hillege H, Klungel O, Goettsch W.

Value Health. 2019 Apr;22(4):399-407. doi: 10.1016/j.jval.2018.11.016.

PMID:
30975390
45.

Risk of myocardial infarction associated with non-steroidal anti-inflammatory drugs: Impact of additional confounding control for variables collected from self-reported data.

Bakhriansyah M, Souverein PC, de Boer A, Klungel OH.

J Clin Pharm Ther. 2019 Aug;44(4):623-631. doi: 10.1111/jcpt.12836. Epub 2019 Apr 7.

46.

Low risk pragmatic trials do not always require participants' informed consent.

Dal-Ré R, Avendaño-Solà C, Bloechl-Daum B, de Boer A, Eriksson S, Fuhr U, Holm S, James SK, Mentz RJ, Perucca E, Rosendaal FR, Treweek S.

BMJ. 2019 Mar 27;364:l1092. doi: 10.1136/bmj.l1092. No abstract available. Erratum in: BMJ. 2019 Apr 1;365:l1518.

PMID:
30917969
47.

Work cessation after cancer diagnosis: a population-based study.

Rottenberg Y, Amir Z, De Boer AGEM.

Occup Med (Lond). 2019 Apr 13;69(2):126-132. doi: 10.1093/occmed/kqz013.

PMID:
30882861
48.

Cyclo-oxygenase selectivity and chemical groups of nonsteroidal anti-inflammatory drugs and the frequency of reporting hypersensitivity reactions: a case/noncase study in VigiBase.

Bakhriansyah M, Meyboom RHB, Souverein PC, de Boer A, Klungel OH.

Fundam Clin Pharmacol. 2019 Oct;33(5):589-600. doi: 10.1111/fcp.12463. Epub 2019 Apr 22.

49.

Heterozygous Deletion of EphrinA5 Does Not Improve Functional Recovery After Experimental Stroke.

de Boer A, Storm A, Rué L, Poppe L, Robberecht W, Lemmens R.

Stroke. 2019 Apr;50(4):e101. doi: 10.1161/STROKEAHA.118.023857. No abstract available.

PMID:
30852969
50.

Melancholia as Predictor of Electroconvulsive Therapy Outcome in Later Life.

Veltman EM, de Boer A, Dols A, van Exel E, Stek ML, Sienaert P, Bouckaert F, van der Mast R, Rhebergen D.

J ECT. 2019 Mar 5. doi: 10.1097/YCT.0000000000000579. [Epub ahead of print]

PMID:
30844880

Supplemental Content

Loading ...
Support Center